What “pharmaceutical-grade” actually means
Grey-market vendors borrow the language of legitimacy — “99% pure,” “lab tested,” “GMP.” This page shows the real thing: the regulated manufacturers whose peptides go into approved medicines, so you have a true benchmark to judge everything else against.
GMP vs. the grey market
Pharmaceutical-grade peptide APIs are made under current Good Manufacturing Practice (cGMP) in facilities registered with and physically inspected by regulators (FDA, EMA, Swissmedic), with validated processes, batch records, released Certificates of Analysis, identity/purity/potency assays, impurity and residual-solvent limits, sterility and endotoxin testing for injectables, stability programs, and full traceability — every lot is accountable to a regulator and tied to an approved or filed drug. Grey-market 'research peptides' skip all of this: sellers use a 'research use only / not for human consumption' label to sidestep FDA oversight and any obligation to prove sterility, dose accuracy, or purity — so products vary widely, impurities can drive immune reactions, and there is essentially no adverse-event monitoring. GMP means an inspected, documented, tested, traceable supply chain behind an approved medicine; grey-market means an unregulated chemical sold on trust with the legal fiction that it is 'not for humans.'
Regulated manufacturers
Who makes the real thing
Publicly documented, regulator-inspected peptide manufacturers. VialGrade does not sell these or claim any grey-market vendor sources from them — they are here purely as a reference point.
Bachem AG
Switzerland · Public (SIX: BANB)
The most-cited reference standard: a >50-year-old, publicly traded pure-play peptide CDMO whose APIs go into FDA-approved medicines.
Makes: GMP peptide & oligonucleotide APIs — research-grade through commercial APIs in approved drugs
Regulatory: FDA / Swissmedic GMP-inspected; files DMFs/CEPs; full pharmaceutical QA/QC
PolyPeptide Group AG
Switzerland · Public (SIX: PPGN) — under a pending Samsung Biologics acquisition
The other publicly listed pure-play peptide CDMO alongside Bachem — a transparent regulatory/financial benchmark.
Makes: Peptide & oligonucleotide APIs, pre-clinical to commercial; 1,000+ peptides made in GMP
Regulatory: Global network of FDA-inspected GMP sites supplying commercial APIs
CordenPharma
Luxembourg / US (Boulder, CO) · Private (Astorg-owned)
A leading large-capacity legitimate peptide CDMO supplying commercial GMP APIs, notably for GLP-1 demand.
Makes: Full-service GMP CDMO: peptide APIs + sterile fill-finish; among the largest peptide-API sites worldwide
Regulatory: cGMP facilities inspected by FDA, EMA, ANVISA, TGA
AmbioPharm, Inc.
USA (North Augusta, SC) + Shanghai · Private
A significant US-based, FDA-inspected GMP peptide API source — legitimate domestic commercial-scale manufacturing.
Makes: Peptide APIs via SPPS / solution / hybrid synthesis, pre-clinical to commercial
Regulatory: cGMP facilities FDA-inspected (incl. pre-approval inspections); files DMFs
Novo Nordisk A/S
Denmark (Kalundborg) + US · Public (NYSE: NVO)
Defines the true reference source for semaglutide. Grey-market 'semaglutide' is NOT sourced from Novo Nordisk and is not the FDA-approved product.
Makes: Innovator and maker of the semaglutide API in the approved drugs Ozempic, Wegovy, Rybelsus
Regulatory: Fully FDA-regulated innovator; semaglutide API and products are NDA-approved
Lonza Group AG
Switzerland · Public (SIX: LONN)
One of the top-tier regulated peptide-API capacity holders, named alongside Bachem/PolyPeptide/CordenPharma.
Makes: Large diversified CDMO with peptide/oligo ('TIDES') API capacity
Regulatory: Extensive FDA/EMA-inspected cGMP network
The honest takeaway: a grey-market vendor posting a high-purity COA is not the same as a regulated manufacturer with an inspected, traceable, released batch behind an approved drug. Purity on a certificate is one data point — it says nothing about sterility, dose accuracy, contaminants, or whether the tested vial matches the one shipped to you. Use the manufacturers above as the bar, and treat everything else as what it is: unregulated material sold on trust.